scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.20.3.715 |
P698 | PubMed publication ID | 10712396 |
P2093 | author name string | M Minami | |
T Kita | |||
H Kataoka | |||
T Masaki | |||
T Sawamura | |||
N Kume | |||
T Murase | |||
P433 | issue | 3 | |
P304 | page(s) | 715-720 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Identification of soluble forms of lectin-like oxidized LDL receptor-1 | |
P478 | volume | 20 |
Q59703917 | Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice |
Q90594287 | Analysis of the oxidized low density lipoprotein receptor 1 gene as a potential marker for carcass quality traits in Qinchuan cattle |
Q36582332 | Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon |
Q92021254 | Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis |
Q90055176 | C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity |
Q34769808 | CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme |
Q34504642 | Caloric restriction, aerobic exercise training and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese post-menopausal women |
Q59744902 | Circulating Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 are Associated with Inflammatory Markers |
Q83603579 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease |
Q51364804 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease. |
Q45045801 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI. |
Q38589168 | Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics |
Q91742069 | Comprehensive assessment of candidate genes associated with fattening performance in Holstein-Friesian bulls |
Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
Q46278173 | Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases |
Q37979643 | Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis |
Q37181325 | Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women |
Q39255621 | Emerging roles of calpain proteolytic systems in macrophage cholesterol handling |
Q58915134 | Evolution of the C-type lectin-like receptor genes of the DECTIN-1 cluster in the NK gene complex |
Q37398560 | High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study |
Q64241987 | High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke |
Q64234050 | Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study |
Q102211122 | Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome |
Q83912399 | Impact of interleukin-17 on macrophage phagocytosis of apoptotic neutrophils and particles |
Q50059271 | Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack |
Q34079451 | LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. |
Q30418436 | LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men. |
Q40376526 | LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells |
Q38128195 | LOX-1, a new marker of risk and prognosis in coronary artery disease? |
Q34774368 | LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis |
Q37721609 | Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation |
Q37156897 | Low CD36 and LOX-1 Levels and CD36 Gene Subexpression Are Associated with Metabolic Dysregulation in Older Individuals with Abdominal Obesity. |
Q36210626 | Molecular and cellular mechanisms of ectodomain shedding |
Q34674199 | New scavenger receptors and their functions in atherogenesis |
Q43129888 | Pitavastatin reduces lectin-like oxidized low-density lipoprotein receptor-1 ligands in hypercholesterolemic humans. |
Q35955255 | Pregnancy followed by delivery may affect circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in women of reproductive age. |
Q44697204 | Refolding and characterization of the functional ligand-binding domain of human lectin-like oxidized LDL receptor |
Q54968443 | Role of sLOX-1 in intracranial artery stenosis and in predicting long-term prognosis of acute ischemic stroke. |
Q34218552 | Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease |
Q92824807 | Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome |
Q33660782 | Significance of soluble lectin-like oxidized LDL receptor-1 levels in systemic and coronary circulation in acute coronary syndrome. |
Q47145447 | Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation. |
Q92419631 | Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection? |
Q26830278 | Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases |
Q38025997 | The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex |
Q83311143 | The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia |
Q35475499 | The discovery of LOX-1, its ligands and clinical significance |
Q35212599 | The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions |
Q39324569 | The production of soluble C-type lectin-like receptor 2 is a regulated process |
Q47785324 | The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice. |
Q37119512 | Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels |